What it is
In this study, we report an artificial neuroimmune axis (NeuroAxis) as a closed-loop immunomodulatory therapy for treating metabolic diseases. Analogous to its biological counterpart, NeuroAxis is solely powered by endogenous glucose, operating without batteries or wireless power transfer.
Every metric behind this entry is listed, with its source, under Sources and data below.
Filed underPancreatic function and diabetes, Vagus Nerve Stimulation Research, Diabetes Management and Research